Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?
暂无分享,去创建一个
[1] J. Pivik,et al. A consumer involvement model for health technology assessment in Canada. , 2004, Health policy.
[2] David L. B. Schwappach,et al. Accounting for Tastes , 2012, PharmacoEconomics.
[3] S. Walker,et al. Is there a need for a universal benefit–risk assessment framework for medicines? Regulatory and industry perspectives , 2013, Pharmacoepidemiology and drug safety.
[4] J Gabbay,et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.
[5] Patient aspects and involvement in HTA:: An Academic Perspective , 2011 .
[6] K. Lancaster. A New Approach to Consumer Theory , 1966, Journal of Political Economy.
[7] N. Day,et al. Political participation and democracy in Britain , 1992 .
[8] Louis P Garrison,et al. Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis. , 2007, Health affairs.
[9] L. Doward,et al. Defining patient-reported outcomes. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] Liana Fraenkel,et al. Incorporating Patients’ Preferences Into Medical Decision Making , 2013, Medical care research and review : MCRR.
[11] R. Kane,et al. Methodology for measuring health-state preferences--II: Scaling methods. , 1989, Journal of clinical epidemiology.
[12] PhD Dr. Dennis J. Mazur MD,et al. Patient preferences , 2007, Journal of General Internal Medicine.
[13] D. Schwappach,et al. Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare. , 2006, PharmacoEconomics (Auckland).
[14] Albert Hauber,et al. Patient Preference Methods - A Patient Centered Evaluation Paradigm , 2007 .
[15] John F P Bridges,et al. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. , 2003, Applied health economics and health policy.
[16] G. Rowe,et al. A Typology of Public Engagement Mechanisms , 2005 .
[17] John F P Bridges,et al. Patient-based health technology assessment: A vision of the future , 2007, International Journal of Technology Assessment in Health Care.
[18] M Ryan,et al. Using conjoint analysis to elicit preferences for health care , 2000, BMJ : British Medical Journal.
[19] A. Breckenridge,et al. European Perspective on Risk Management and Drug Safety , 2011, Clinical pharmacology and therapeutics.
[20] M Ryan,et al. Methodological issues in the application of conjoint analysis in health care. , 1998, Health economics.
[21] Maarten J. IJzerman,et al. The Use of Multi-Criteria Decision Analysis Weight Elicitation Techniques in Patients with Mild Cognitive Impairment , 2008, The patient.
[22] W. Groot,et al. The importance of quality, access and price to health care consumers in Bulgaria: a self-explicated approach. , 2003, The International journal of health planning and management.
[23] T. Flynn. Valuing citizen and patient preferences in health: recent developments in three types of best–worst scaling , 2010, Expert review of pharmacoeconomics & outcomes research.
[24] Patricia Flatley Brennan,et al. Review: Improving Health Care by Understanding Patient Preferences: The Role of Computer Technology , 1998, J. Am. Medical Informatics Assoc..
[25] A. Coulter. Perspectives on health technology assessment: response from the patient's perspective , 2004, International Journal of Technology Assessment in Health Care.